NCT00634335

Brief Summary

The purpose of this study is to characterize the cardiac adaptive changes of professional Israeli bicyclists by using echocardiography.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
81

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2008

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2008

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 4, 2008

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 13, 2008

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
Last Updated

December 30, 2008

Status Verified

February 1, 2008

Enrollment Period

1 year

First QC Date

March 4, 2008

Last Update Submit

December 29, 2008

Conditions

Study Arms (1)

sk

professional Israeli bicyclists

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

professional bicyclists in Israel

You may qualify if:

  • Known athletes of the bicyclists organization of Israel or any other known organization for 2 year at least.
  • Participated in at least one contest recognized by the bicyclists organization of Israel.
  • Had been in training for the last 3 months at least, which included minimum of 8 hours a week in average

You may not qualify if:

  • Do not suffer any known cardiac disease
  • Had declared that they are not using drugs which are forbidden by the Olympic committee

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Soroka University Medical Center

Beersheba, Israel

RECRUITING

Study Officials

  • Sergio Kobal, MD

    Soroka medical center, Israel

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sergio Kobal, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 4, 2008

First Posted

March 13, 2008

Study Start

March 1, 2008

Primary Completion

March 1, 2009

Study Completion

June 1, 2009

Last Updated

December 30, 2008

Record last verified: 2008-02

Locations